RE: Val 201 trial23 Aug 2020 02:44
I agree the market cap should be higher, however a lot will depend on the next RNS will the results. That looks like it will have to be after the 7th of Sept due do a director share purchase. It is my understanding that it has to be a month after the purchase date.
We will have to wait and see.
I wonder if Grace can interpret the results for us and tell us how important they are? If they good enough to get a big pharmaceutical interested. If so, we are on a winner. That would bring us to a similar m cap as some of the other pharmaceutical companies.
Again we will have to wait and see.
If the results are good enough we need to get the share price over 15p for 5 days and get Val more capital to work with. If Val is in the position to finance its own research, it puts Val in a stronger position when dealing with the big pharmaceutical companies.